PDS Biotechnology Corporation

NASDAQ:PDSB

Biotechnology

Healthcare
$0.92 +1.21%

+$0.01 today

Market cap
$51.58M
Beta
1.56
P/E (TTM)
-1.5
EPS (TTM)
-$0.60
52W Low $0.51High $1.67

Volume 5.25M

Average 1.04M

Returns on capital

PDS Biotechnology Corporation management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-372.9%

avg -114.0%

ROIC

-116.5%

avg -64.6%

ROA

-113.1%

avg -60.6%

Analysis

ROA is currently the strongest return metric at -113.1% versus its period average of -60.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Frank K. Bedu-Addo

Founder, President, CEO, Interim CFO & DirectorUSD 634.81K61——

Kirk V. Shepard

Chief Medical OfficerUSD 483.82K74300.00K0.54%

Stephan Toutain

Chief Operating OfficerUSD 480.13K60300.00K0.54%

Gregory L. Conn

Chief Scientific OfficerUSD 194.67K70——

Janetta Trochimiuk

Controller & Interim Principal Accounting Officer—630<0.01%

Lars Robert Boesgaard

Principal Financial & Accounting Officer and Chief Financial Officer—56——

Spencer Brown

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer—56——

Compensation is shown in the reported currency; data updated Oct 10, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 12, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does PDS Biotechnology Corporation compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about PDSB's management, answered from reported figures.

Who manages PDSB?

PDS Biotechnology Corporation (PDSB) lists 7 active executives. The top listed executive is Frank K. Bedu-Addo, Founder, President, CEO, Interim CFO & Director.

Are PDSB insiders buying or selling?

Recent insider activity shows net buying of $14.92M.